viking therapeutics – board of directors board of directors matthew w foehr mr foehr has served as executive vice president and chief operating officer at ligand pharmaceuticals incorporated since april  and has  years of experience in the pharmaceutical industry having managed global operations and research and development programs prior to ligand he was vice president and head of consumer dermatology rd as well as acting chief scientific officer of dermatology in the stiefel division of gsk following gsk’s  billion acquisition of stiefel laboratories inc a pharmaceutical company in  mr foehr led the rd integration of stiefel into gsk at stiefel laboratories inc mr foehr served as senior vice president of global rd operations senior vice president of product development  support and vice president of global supply chain technical services prior to stiefel mr foehr held various executive roles at connetics corporation a pharmaceutical company including senior vice president of technical operations and vice president of manufacturing early in his career mr foehr managed manufacturing activities and worked in process sciences at both lxr biotechnology inc and berlex biosciences mr foehr is the author of multiple scientific publications and is named on numerous us patents he received his bachelor of science degree in biology from santa clara university lawson macartney dvm phd dr macartney has served as president chief executive officer and a member of the board of directors of ambrx inc a biopharmaceutical company since february  prior to ambrx dr macartney served at shire ag a specialty biopharmaceutical company as senior vice president of the emerging business unit where he was responsible for discovery initiatives through phase  development of shire’s specialty pharmaceutical portfolio prior to joining shire ag he served at gsk a pharmaceutical company from  to  serving as senior vice president of global product strategy and projectportfolio management from  to  as senior vice president cardiovascular and metabolic medicine development center from  to  and as vice president global head of cardiovascular metabolic and urology therapeutic areas from  to  prior to joining gsk dr macartney was employed at astra pharmaceuticals in leadership roles in operations marketing and sales and served as executive director commercial operations at astramerck inc a pharmaceutical company dr macartney received his phd from glasgow university in scotland where he was a royal society research fellow and his bvms equivalent to a dvm from glasgow university veterinary school he is also trained in diagnostic pathology and is a fellow of the royal college of pathologists charles a rowland jr mr rowland has more than  years of biopharmaceutical industry experience and is currently a board member and strategic advisor for multiple biotechnology companies he most recently served as the president and chief executive officer ceo of aurinia pharmaceuticals a clinical stage pharmaceutical company focused on the global lupus nephritis market prior to his tenure with aurinia pharmaceuticals he was the vice president and chief financial officer cfo of viropharma during which time the company grew into a global biopharmaceutical business with  million in annual revenues until it was acquired by shire plc for  billion before joining viropharma mr rowland was executive vice president and cfo as well as interim coceo for endo pharmaceuticals a specialty pharmaceutical company with  billion in revenues he previously held finance and operational positions of increasing responsibility at biovail pharmaceuticals breakaway technologies pharmacia novartis and bristolmyers squibb mr rowland currently serves as a member of the board of directors for blueprint medicines and nabriva therapeutics with previous board appointments including vitae pharmaceuticals bind therapeutics aurinia pharmaceuticals and idenix pharmaceuticals among others mr rowland holds an mba from rutgers university and a bachelor of science degree from saint joseph’s university matthew singleton in october  mr singleton retired from his position as executive vice president and chief financial officer of citationair formerly citationshares llc a privatelyheld jet services company whollyowned by textron inc a public industrial conglomerate he had served in this position since  mr singleton has extensive financial accounting and transactional experience including through his role as managing director executive vice president and chief administrative officer of cibc world markets an investment banking company for  years at arthur andersen  co a public accounting firm including as partnerincharge of the metro new york audit and business advisory practice and as a practice fellow at the financial accounting standards board a private organization responsible for establishing financial accounting reporting standards from  until  mr singleton served as a director of cubist pharmaceuticals inc and as audit committee chair beginning in  mr singleton previously served as an independent director of salomon reinvestment company inc a privatelyheld investment services company mr singleton received an ab in economics from princeton university and his mba from new york university with a focus in accounting stephen w webster mr webster has served as chief financial officer of spark therapeutics a biotechnology company since july  he was previously svp and chief financial officer of optimer pharmaceuticals inc a biotechnology company from  to  until its acquisition by cubist pharmaceuticals inc prior to joining optimer mr webster served as svp and chief financial officer of adolor corporation a biopharmaceutical company from june  until its acquisition by cubist pharmaceuticals inc in december  prior to adolor mr webster served as managing director investment banking division health care group for broadpoint capital inc formerly first albany capital mr webster previously served as cofounder president and chief executive officer for neuronyx inc a biopharmaceutical company prior to neuronyx mr webster served in positions of increased responsibility including as director investment banking division health care group for painewebber incorporated he previously served as a director of hearusa now husa liquidating corporation a public company specializing in hearing care from  and he currently serves as a director of the pennsylvania biotechnology association mr webster holds an ab in economics cum laude from dartmouth college and an mba in finance from the wharton school of the university of pennsylvania brian lian phd dr lian’s bio is provided under management     matthew w foehr  executive bio compensation history and contacts  equilar atlas   log in  sign up x   as featured in matthew w foehr president and chief operating officer at ligand pharmaceuticals incorporated view full profile are you matthew w foehr claim your profile   sign up for equilar atlas and view matthew w foehrs full profile with equilar atlas you can identify corporate executives in matthew w foehrs network and community follow changes in matthew w foehrs employment and moneyinmotion connect with matthew w foehr through your network of contacts matthew w foehrs executive work history current president and chief operating officer ligand pharmaceuticals incorporated board member viking therapeutics inc board member ritter pharmaceuticals inc past to view matthew w foehrs complete executive work history sign up now age      matthew w foehrs biography matthew w foehr  has been our president and chief operating officer since january  prior to that time mr foehr served as our executive vice president and chief operating officer since  and has more than  years of experience managing global research and development programs prior to joining ligand in  he was vice president and head of consumer dermatology rd as well as acting chief scientific officer of dermatology in the stiefel division of glaxosmithkline gsk following gsks  billion acquisition of stiefel in  mr foehr led the rd integration of stiefel into gsk at stiefel laboratories inc mr foe  read more matthew w foehr  has been our president and chief operating officer since january  prior to that time mr foehr served as our executive vice president and chief operating officer since  and has more than  years of experience managing global research and development programs prior to joining ligand in  he was vice president and head of consumer dermatology rd as well as acting chief scientific officer of dermatology in the stiefel division of glaxosmithkline gsk following gsks  billion acquisition of stiefel in  mr foehr led the rd integration of stiefel into gsk at stiefel laboratories inc mr foehr served as senior vice president of global rd operations senior vice president of product development  support and vice president of global supply chain technical services prior to stiefel mr foehr held various executive roles at connetics corporation including senior vice president of technical operations and vice president of manufacturing mr foehr serves on the board of directors of viking therapeutics inc and ritter pharmaceuticals inc mr foehr is the author of multiple scientific publications and is named on numerous us patents he received his bs degree in biology from santa clara university source ligand pharmaceuticals incorporated on    sign up for equilar atlas and view matthew w foehrs full profile by accessing equilar atlas you can view bios network salary and wealth events of industryleading executives like matthew w foehr more specifically youll be able to identify corporate executives in matthew w foehrs network and community follow changes in matthew w foehrs employment and moneyinmotion connect with matthew w foehr through your network of conections view full profile   search for over  executive profiles bio example matthew w foehr matthew w foehrs connections  sign up now to view matthew w foehrs  connections » john l lamattina board member zafgen inc leon e panetta board member oracle corporation syed m kazmi former consultant ligand pharmaceuticals incorporated thomas g wiggans chief executive officer and chairman of the board dermira inc r andrew eckert chairman of the board varian medical systems inc nishan m de silva former vice president finance and strategy and chief financial officer ligand pharmaceuticals incorporated david e cohen former board member dermira inc matthew e korenberg vice president finance and chief financial officer ligand pharmaceuticals incorporated gerald t proehl board member tenax therapeutics inc stephen w webster chief financial officer spark therapeutics inc popular profiles sign up now to view more executive profiles » thomas j lynch executive chairman te connectivity ltd john j kita evp and cfo a o smith elon r musk ceo and chairman tesla david j oconnor president and ceo the madison square garden company claiborne p deming chairman of the board murphy oil corporation × claim your profile coming soon interested in updating your biography and work history were working on making it happen well email you when this feature is available please enter valid email address done thank you for your interest ok browse executive profiles  a  b  c  d  e  f  g  h  i  j  k  l  m  n  o  p  q  r  s  t  u  v  w  x  y  z equilar homepage equilar atlas equilar insight equilar boardedge equilar engage research services knowledge network about us login �  equilar all rights reserved privacy policy  marshall street redwood city ca   phone    fax   ligand promotes matthew w foehr to president  ligand pharmaceuticals inc lgnd news investors investor summary investor summary analysts news  events press releases investor presentations scientific presentations ir calendar email alerts stock data quote charts historical data sec filings all sec filings annual reports quarterly reports section  filings governance governance governance documents nasdaq lgnd press releases navigate investors ligand promotes matthew w foehr to president download as pdf february   san diego ligand pharmaceuticals incorporated nasdaq lgnd announces that matthew w foehr has been promoted to president and chief operating officer previously mr foehr served as the company’s executive vice president and chief operating officer john higgins who had been serving as president and chief executive officer will continue to serve as the company’s chief executive officer “i am delighted to share with our investors and partners news of matt’s promotion to president” said john higgins chief executive officer of ligand “matt is an accomplished pharmaceutical executive and a fantastic colleague who has played a critically important role in helping build ligand over the past several years he is a perfect fit for our business driving excellence in operations managing successful programs with tight financial discipline and having keen vision for how to strategically grow our business ligand’s internal team and our partners know matt for his strong commitment to the customer untiring energy and sense of humor his contributions to ligand over the past four years have been profound on behalf of my colleagues and the ligand board of directors i extend deep congratulations to him on this welldeserved promotion” mr foehr has more than  years of experience in the pharmaceutical industry having managed global operations and various research and development programs prior to joining ligand in  he was vice president and head of consumer dermatology rd as well as acting chief scientific officer of dermatology in the stiefel division of glaxosmithkline gsk gsk acquired stiefel in  for  billion at stiefel laboratories inc mr foehr served as senior vice president of global rd operations senior vice president of product development  support and vice president of global supply chain technical services prior to stiefel mr foehr held various executive roles at connetics corporation including senior vice president of technical operations and vice president of manufacturing mr foehr serves on the board of directors of ritter pharmaceuticals inc and viking therapeutics inc he is the author of multiple scientific publications and is named on numerous us patents he received a bachelor of science degree in biology from santa clara university about ligand pharmaceuticals ligand is a biopharmaceutical company with a business model that is based upon the concept of developing or acquiring royalty generating assets and coupling them with a lean corporate cost structure ligand’s goal is to produce a bottom line that supports a sustainably profitable business by diversifying the portfolio of assets across numerous technology types therapeutic areas drug targets and industry partners we offer investors an opportunity to invest in the increasingly complicated and unpredictable pharmaceutical industry in comparison to its peers we believe ligand has assembled one of the largest and most diversified asset portfolios in the industry with the potential to generate revenue in the future these therapies seek to address the unmet medical needs of patients for a broad spectrum of diseases including diabetes hepatitis muscle wasting alzheimer’s disease dyslipidemia anemia asthma and osteoporosis ligand’s captisol platform technology is a patentprotected chemically modified cyclodextrin with a structure designed to optimize the solubility and stability of drugs ligand has established multiple alliances with the worlds leading pharmaceutical companies including glaxosmithkline onyx pharmaceuticals a subsidiary of amgen inc merck pfizer baxter international lundbeck inc eli lilly  co and spectrum pharmaceuticals please visit wwwcaptisolcom for more information on captisol and wwwligandcom for more information on ligand follow ligand on twitter ligandlgnd ligand pharmaceuticals incorporatedjohn l higgins ceo orlhabruce voss bvosslhaicom source ligand pharmaceuticals incorporated released february   matthew foehr  ligand pharmaceuticals incorporated  zoominfocom lgnd matthew w foehr insider trades for ligand pharmaceuticals inc bulletin investor alert expand keep open close expand keep open close expand keep open close expand keep open close expand keep open close ligand pharmaceuticals inc nasdaq lgnd go set alerts find a broker join td ameritrade market index overview profile news charts financials historical quotes analyst estimates options sec filings insiders marketstatecountryus ligand pharmaceuticals inc after hours  quotes are delayed by  min jul    pm lgnd quoteszigmancomposite   change   volume volume  quotes are delayed by  min quoteszigmancomposite previous close     change   day low day high    week low  week high   insider activity individual matthew w foehr mr matthew w foehr is independent director at ritter pharmaceuticals inc and president  chief operating officer at ligand pharmaceuticals inc he is on the board of directors at ritter pharmaceuticals inc and viking therapeutics inc mr foehr was previously employed as senior vice presidenttechnical operations by connetics corp chief scientific officerdermatology  vp by glaxosmithkline llc and senior vpglobal research  development operations by stiefel research institute inc he received his undergraduate degree from santa clara university transactions date shares transaction value     derivativenonderivative trans at  per share      disposition at  per share      derivativenonderivative trans at  per share      derivativenonderivative trans at  per share      disposition at  per share      derivativenonderivative trans at  per share      award at  per share      derivativenonderivative trans at  per share      award at  per share      derivativenonderivative trans at  per share      derivativenonderivative trans at  per share      derivativenonderivative trans at  per share      disposition at  per share      derivativenonderivative trans at  per share      derivativenonderivative trans at  per share      disposition at  per share      derivativenonderivative trans at  per share      derivativenonderivative trans at  per share      award at  per share      derivativenonderivative trans at  per share      disposition at  per share      derivativenonderivative trans at  per share      derivativenonderivative trans at  per share      disposition at  per share      disposition at  per share      disposition at  per share      derivativenonderivative trans at  per share      award at  per share      acquisition at  per share      derivativenonderivative trans at  per share      acquisition at  per share      acquisition at  per share      disposition at  per share      derivativenonderivative trans at  per share      derivativenonderivative trans at  per share      award at  per share      acquisition at  per share      disposition at  per share      derivativenonderivative trans at  per share      acquisition at  per share      award at  per share      award at  per share      acquisition at  per share  copyright  factset research systems inc all rights reserved source factset fundamentals officers and executives mr john l higgins chief executive officer  director mr matthew w foehr president  chief operating officer mr matthew e korenberg cfo principal accounting officer  vpfinance dr vincent antle vptechnical operations  quality assurance dr james d pipkin vice presidentnew product development mr glenn dourado senior directorbusiness development mr todd pettingill investor relations contact ms audrey warfieldgraham vice presidenthuman resources mr charles s berkman secretary vice president  general counsel dr john w kozarich chairman mr todd c davis independent director mr jason m aryeh independent director dr john l lamattina independent director mr sunil patel independent director dr stephen l sabba independent director trending tickers quoteszigmancomposite vuzi quoteszigmancomposite jcp quoteszigmancomposite nugt quoteszigmancomposite jnug quoteszigmancomposite tlt x powered by log in  am edt july   marketstatecountryus new york closed marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest ptrump says he has ‘complete power to pardon’ plawmakers reach deal on russia sanctions bill reports palphabet earnings a  billion hit for google potential youtube results for investors pyou can date someone who looks just like donald trump with this new online service pwant to buy happiness splurge on these  things pthis is what people really buy when they emotionally overspend hint it’s not designer clothes pjohn mccain is a war hero — but think twice before saying he’s ‘battling’ cancer pthe dark side of cruises pi want to buy my brothers out of our family home — but they want me to pay future sales fees poj simpson made over  while in prison and won’t have to give any of it to the goldman family pnot even free money can make some people go to the gym phow realestate tv shows determine what buyers look for in a house pwhat eleanor roosevelt and helen gurley brown ate — and what we can learn from it pnote to parents this social network was rated the worst for teenage cyberbullying pif like sean spicer you suddenly quit your job — what should you do next pthis is the deadliest time of your life to put on weight p unfortunate reasons why millennials can’t have nice things or save any money pus giving takeover bids by chinese firms much tougher look pjared kushner discloses dozens of additional assets in revised filing pbitcoin surges as miners avert split for now loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  matthew foehr president and chief operating officer ligand pharmaceuticals timesjavascript is disabled market profiles login sign up login sign up   edit person matthew foehr president and chief operating officer at ligand pharmaceuticals location greater san diego area add to my lists claim share copy the following code on your pageblog suggested widget size mobile desktop matthew foehr president and chief operating officer at ligand pharmaceuticals location greater san diego area add to my lists claim share copy the following code on your pageblog suggested widget size mobile desktop matthew w foehr has  years of experience in the pharmaceutical industry having managed global operations and research and development programs prior to joining ligand in  he was vice president and head of consumer dermatology rd as well as acting chief scientific officer of dermatology in the stiefel division of glaxosmithkline gsk following gsk’s  billion acquisition of stiefel in  mr foehr led the rd integration of stiefel into gsk at stiefel laboratories inc mr foehr served as senior vice president of global rd operations senior vice president of product development  support and vice president of global supply chain technical services prior to stiefel mr foehr held various executive roles at connetics corporation including senior vice president of technical operations and vice president of manufacturing currently he is a director on the boards of ritter pharmaceuticals and viking therapeutics inc mr foehr is the author of multiple scientific publications and is named on numerous us patents he received his bachelor of science degree in biology from santa clara university  companies in career na related markets na colleagues na related investments alias na industry pharmaceuticals tags na topics of influence na na careers achievements investments related people edit view all matthew foehrcareer  feb ritter pharmaceuticals board member may viking therapeutics board member apr ligand pharmaceuticals president and chief operating officer jan to apr stiefel vice president head of consumer dermatology rd  to feb stiefel laboratories senior vice president global rd operations  to  stiefel laboratories vice president global supply chain technical services competencies edit view all matthew foehreducation  santa clara university biology edit matthew foehrachievements and recognitions add milestone no milestones has been recorded for matthew foehr edit matthew foehrlinks add link no links has been recorded for matthew foehr matthew foehrinvestmentsacquisitions no investments has been recorded for matthew foehr matthew foehrinvestments representing others no investment reps has been recorded for matthew foehr matthew foehrrelated people no colleagues and peers has been recorded for matthew foehr view all matthew foehrrecommended market profiles  telemedicine  or more employees  companies social media marketing chiefmarteccom    employees  companies big data universe list of lists  or more employees  companies aggregated marketing technology  or more employees  companies shared economy landscape jeremiah owyang  or more employees  companies inside sales landscape  or more employees  companies rttr matthew w foehr insider trades for ritter pharmaceuticals inc bulletin investor alert expand keep open close expand keep open close expand keep open close expand keep open close expand keep open close ritter pharmaceuticals inc nasdaq rttr go set alerts find a broker join td ameritrade market index overview profile news charts financials historical quotes analyst estimates options sec filings insiders marketstatecountryus ritter pharmaceuticals inc after hours  quotes are delayed by  min jul    pm rttr quoteszigmancomposite   change   volume volume  quotes are delayed by  min quoteszigmancomposite previous close     change   day low day high    week low  week high   insider activity individual matthew w foehr mr matthew w foehr is president  chief operating officer at ligand pharmaceuticals inc he is on the board of directors at ritter pharmaceuticals inc and viking therapeutics inc mr foehr was previously employed as senior vice presidenttechnical operations by connetics corp chief scientific officerdermatology  vp by glaxosmithkline llc and senior vpglobal research  development operations by stiefel research institute inc he received his undergraduate degree from santa clara university transactions date shares transaction value     acquisition at  per share      acquisition at  per share      acquisition at  per share  copyright  factset research systems inc all rights reserved source factset fundamentals officers and executives mr ira e ritter executive chairman  chief strategic officer mr michael d step chief executive officer  director mr andrew j ritter president  director ms ellen f mochizuki principal financial  accounting officer dr annkatrin petersenjappelli chief medical officer dr william m merino director mr gerald t proehl independent director mr paul v maier independent director mr matthew w foehr independent director mr noah j doyle independent director trending tickers quoteszigmancomposite vuzi quoteszigmancomposite jcp quoteszigmancomposite nugt quoteszigmancomposite jnug quoteszigmancomposite tlt x powered by log in  am edt july   marketstatecountryus new york closed marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest ptrump says he has ‘complete power to pardon’ plawmakers reach deal on russia sanctions bill reports palphabet earnings a  billion hit for google potential youtube results for investors pyou can date someone who looks just like donald trump with this new online service pwant to buy happiness splurge on these  things pthis is what people really buy when they emotionally overspend hint it’s not designer clothes pjohn mccain is a war hero — but think twice before saying he’s ‘battling’ cancer pthe dark side of cruises pi want to buy my brothers out of our family home — but they want me to pay future sales fees poj simpson made over  while in prison and won’t have to give any of it to the goldman family pnot even free money can make some people go to the gym phow realestate tv shows determine what buyers look for in a house pwhat eleanor roosevelt and helen gurley brown ate — and what we can learn from it pnote to parents this social network was rated the worst for teenage cyberbullying pif like sean spicer you suddenly quit your job — what should you do next pthis is the deadliest time of your life to put on weight p unfortunate reasons why millennials can’t have nice things or save any money pus giving takeover bids by chinese firms much tougher look pjared kushner discloses dozens of additional assets in revised filing pbitcoin surges as miners avert split for now loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice    ritter pharmaceuticals inc rttr director foehr matthew ws insider stock buys and sells home homepage membership levels membership data coverage complete stock list founders message the book free trial screeners value screens allinone screener industry overview ben graham netnet undervalued predictable buffettmunger screener magic formula greenblatt historical low ps list historical low pb list peter lynch screen high short interest weekyy lows weekyy highs predictable companies sp  grid dividend stocks spin off list downloads  tools excel addin guruf manual of stocks™ download financial data download guru portfolios download stock pdfs download insider data api mobile app strategies performances buffettmunger undervalued predictable low ps low pb broadest owned most weighted gurus latest guru picks real time picks list of gurus personalize gurus portfolios scoreboard top  holdings view sector picks international picks aggregated portfolio consensus picks guru bargains hot picks industry trends geographic trend etfs options european shorting insiders all insiders ceo buyssales cfo buyssales insider cluster guruinsider double buys triple buyssales insider trends canadian insider dutch insider market market valuation economic data industry overview marketcapgdp valuation global market valuation shiller pe shiller pe by sectors buffett assets allocation by country usa australia canada china germany india japan uk more articles articles editors picks gurufocus research value ideas interviews with gurus top ranked value idea contest videos following authors submit articles writers wanted value contest winners submit articles online my articles conference value conference speakers locationvenue register after conference gathering free drinks tutorials tutorials  webinars faq contact us log in free signup log in day free trial subscribe free trial year refer a friend  earn  search compare search ▾ get day free trial my portfolios▾ portfolios overview create new portfolio portfolio contest my gurus▾ quick browse personalize my gurus premium gurus premium plus investors summarycanadian dutch ceo buys cfo buys insider cluster buys double buys triple buys data export trend saved usa canada ukireland europe asia oceania latin america africa currently selected show all countries ▾ purchase to select this region purchase  usa otcpk nas nyse arca otcbb amex bats purchase to select this region purchase  canada tsxv tsx xcnq purchase to select this region purchase  ukireland uk purchase to select this region purchase  europe germany france poland russia sweden turkey bosnia and herzegovina italy luxembourg switzerland belgium greece norway spain denmark bulgaria netherlands romania finland serbia austria croatia portugal slovakia cyprus macedonia slovenia ukraine hungary lithuania latvia malta iceland estonia czech republic all countries ▾ purchase to select this region purchase  asia india japan korea thailand hongkong china taiwan malaysia singapore israel indonesia pakistan vietnam philippines sri lanka kuwait nepal saudi jordan oman iran iraq united arab emirates kazakhstan bahrain all countries ▾ purchase to select this region purchase  oceania australia new zealand purchase to select this region purchase  latin america brazil mexico argentina chile peru columbia jamaica venezuela ecuador purchase to select this region purchase  africa south africa egypt nigeria mauritius morocco zimbabwe kenya tunisia ghana côte divoire set as default insider trades try insider screener ritter pharmaceuticals inc rttr director foehr matthew ws insider stock buys and sellsto find out why gurufocus thinks data on insider trades is interesting read can aggregated insider trading activities predict the market stocks that both gurus and insiders are buying can aggregated insider trading activities predict the market of different sectors filter by   default search insider trade go select to drill down all market capmicro cap small cap mid cap large cap mega cap sp  companies all sectorsbasic materials consumer cyclical financial services real estate consumer defensive healthcare utilities communication services energy industrials technology display those with at least          shares display stocks that are within please select        of please select week lowyear lowyear lowreal time insider typebuysellinsider sentiment chart recent filings activity total records    page          last   per page ▾      symbol company insider position date buysell shares trade price  cost  price changesince trade  yield  pe market cap m details rttrritter pharmacefoehr matthew wdirectorbuy  link lgndligand pharmacefoehr matthew wpresident and csell  link lgndligand pharmacefoehr matthew wpresident and csell  link vktxviking therapeufoehr matthew wdirectorbuy  link lgndligand pharmacefoehr matthew wpresident and csell  link vktxviking therapeufoehr matthew wdirectorbuy  link lgndligand pharmacefoehr matthew wpresident and csell  link rttrritter pharmacefoehr matthew wdirectorbuy  link lgndligand pharmacefoehr matthew wpresident and csell  link rttrritter pharmacefoehr matthew wdirectorbuy  link lgndligand pharmacefoehr matthew wpresident and csell  link vktxviking therapeufoehr matthew wdirectorbuy  link lgndligand pharmacefoehr matthew wevp and coobuy  link lgndligand pharmacefoehr matthew wevp and coobuy  link lgndligand pharmacefoehr matthew wevp and coobuy  link lgndligand pharmacefoehr matthew wevp and coosell  link lgndligand pharmacefoehr matthew wevp and coobuy  link lgndligand pharmacefoehr matthew wevp and coosell  link lgndligand pharmacefoehr matthew wevp and coobuy  link lgndligand pharmacefoehr matthew wevp and coobuy  link total records    page          last   per page ▾     add this list into my watchlistportfolio  add or remove tickers comma separated up to  symbols rttr lgnd vktx  select destination portfolioyou need to log in to proceed  click the button to finish related news and stories r stocknote r comment on r r note of r r keeley funds comments on ryder systems r note of r r note of r r note of r r note of r r note of r r comment on r r note of r r comment on r r comment on r r ryder system inc fundamental stock research analysis r ryder system inc r evp  cfo art a garcia sells  shares  only the transactions in open market or private sale at the market prices are included other transactions such as conversion of derivative security or exercise of options are not included insiders are limited to only officers andor directors of the company select portfolios create a new portfolio why you are interested your selection and notes will be stored in your portfolio login to add portfolio get wordpress plugins for easy affiliate links on stock tickers and guru names  earn affiliate commissions by embedding gurufocus charts gurufocus affiliate program earn up to  per referral  learn more home  about   jobs   advertise    site map    term of use    privacy policy     rss    mobile app     email alerts    referral program    affiliate program    faq    contact us      gurufocuscom llc all rights reserved disclaimers gurufocuscom is not operated by a broker a dealer or a registered investment adviser under no circumstances does any information posted on gurufocuscom represent a recommendation to buy or sell a security the information on this site and in its related newsletters is not intended to be nor does it constitute investment advice or recommendations the gurus may buy and sell securities before and after any particular article and report and information herein is published with respect to the securities discussed in any article and report posted herein in no event shall gurufocuscom be liable to any member guest or third party for any damages of any kind arising out of the use of any content or other material published or available on gurufocuscom or relating to the use of or inability to use gurufocuscom or any content including without limitation any investment losses lost profits lost opportunity special incidental indirect consequential or punitive damages past performance is a poor indicator of future performance the information on this site and in its related newsletters is not intended to be nor does it constitute investment advice or recommendations the information on this site is in no way guaranteed for completeness accuracy or in any other way the gurus listed in this website are not affiliated with gurufocuscom llc stock quotes provided by interactive data fundamental company data provided by morningstar updated daily gf chat  × manage bookmarks close feedback matthew foehr ligand pharmaceuticals inc profile  biography  bloomberg feedback matthew matt foehr presidentcoo ligand pharmaceuticals inc career history presidentcoo ligand pharmaceuticals inc present exec vpcoo ligand pharmaceuticals inc  vpheadconsumer dermatology glaxosmithkline plc  vpmanufacturing connetics corp  various positions connetics corp  senior vptechnical operations connetics corp unknown senior vpglobal rd ops stiefel laboratories inc former acting chief scientific ofcr glaxosmithkline plc former show more website wwwligandcom corporate information address  sorrento valley blvd suite  san diego ca  united states phone  fax  web url wwwligandcom from the web personal information education santa clara university bachelors degree biology memberships board memberships ritter pharmaceuticals inc board member present viking therapeutics inc board member present sponsored financial commentaries more from the web home news top headlines most popular exclusive law entrepreneurs leaders economy environment science sports markets magazine pursuits magazine bloomberg visual data bloomberg best and worst for comments or complaints about news coverage click here regions us china europe asia uk  ireland australia  new zealand canada india  pakistan japan africa eastern europe latin america middle east markets commodities currencies bonds stocks energy markets municipal bonds emerging markets funds islamic finance industries energy technology real estate finance health care transportation insurance retail media manufacturing quick market data stocks stock futures world indexes americas europe middle east  africa asiapacific gainers  losers earnings calendar industry leaders currencies americas europe middle east  africa asiapacific foreign exchange cross rates fx fixings currency converter forex trading videos commodities energy prices metals prices agricultural prices rates  bonds us treasuries uk gilts germany bunds japan bonds australia bonds bloomberg bond indexes corporate bonds consumer rates economic calendar watchlist european debt crisis symbol search the market now personal finance top headlines saving  investing real estate retirement planning financial advisers taxes blog ventured  gained real cost of money gallery calculators watchlist portfolio tracker tech top headlines social media mobile  wireless web enterprise tech tv games  movies apple tech deals global tech slideshows videos us politics sustainability top headlines energy corporate sustainability policy natural resources health  population slideshows videos blog the grid luxury top headlines autos billionaires living property travel well spent loot blog pursuits magazine videos tv live tv channel finder personalities apple tv ipad app schedule us asia europe shows surveillance market makers lunch money street smart bloomberg west game changers video must see latest live tv shows playlist radio live radio shows schedule personalities podcasts bloomberg brief featured podcasts and new shows bloomberg view masters in business first word surveillance bloomberg advantage in the loop bloomberg law taking stock bloomberg best more podcasts blogs global tech the grid loot the market now political capital tech deals ventured and gained opinion my saved registration sign in bloombergcom businessweekcom company about blog careers diversity  inclusion news mission philanthropy  engagement press room procurement sustainability products financial products bloomberg professional service bloomberg anywhere bloomberg tradebook bloomberg briefs bloomberg indexes bloomberg sef service center customer support enterprise products enterprise solutions trading solutions industry products bloomberg bna bloomberg government bloomberg law bloomberg link bloomberg new energy finance bloomberg sports content licensing bloomberg anywhere mobile apps bloomberg visual data